Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunctionJunquan Song, Xiaowen Liu, Pengcheng He et al.|Molecular Medicine|2022Cited by 39
Pan-Cancer Analysis Reveals RIPK2 Predicts Prognosis and Promotes Immune Therapy Resistance Via Triggering Cytotoxic T Lymphocytes DysfunctionJunquan Song, Xiaowen Liu, Runyu Yang et al.|Research Square|2021Cited by 0